Accuray (ARAY) Competitors $1.62 -0.13 (-7.18%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARAY vs. OFIX, ANGO, SRDX, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDTShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Accuray vs. Orthofix Medical AngioDynamics Surmodics Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Which has stronger valuation & earnings, OFIX or ARAY? Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$804.53M0.58-$151.40M-$3.69-3.25Accuray$465.25M0.39-$15.55M-$0.05-34.80 Do analysts prefer OFIX or ARAY? Orthofix Medical presently has a consensus target price of $23.33, suggesting a potential upside of 94.61%. Given Orthofix Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Orthofix Medical is more favorable than Accuray.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Accuray 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is OFIX or ARAY more profitable? Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-15.18% -21.25% -13.29% Accuray -0.96%-9.75%-0.93% Does the media prefer OFIX or ARAY? In the previous week, Orthofix Medical had 1 more articles in the media than Accuray. MarketBeat recorded 3 mentions for Orthofix Medical and 2 mentions for Accuray. Orthofix Medical's average media sentiment score of 1.80 beat Accuray's score of 1.06 indicating that Orthofix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Accuray 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in OFIX or ARAY? Orthofix Medical received 81 more outperform votes than Accuray when rated by MarketBeat users. However, 65.44% of users gave Accuray an outperform vote while only 62.11% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformOrthofix MedicalOutperform Votes41862.11% Underperform Votes25537.89% AccurayOutperform Votes33765.44% Underperform Votes17834.56% Do insiders and institutionals hold more shares of OFIX or ARAY? 89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 1.3% of Orthofix Medical shares are owned by insiders. Comparatively, 4.2% of Accuray shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, OFIX or ARAY? Orthofix Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500. SummaryOrthofix Medical beats Accuray on 10 of the 18 factors compared between the two stocks. Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$179.24M$4.54B$5.43B$8.48BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-34.8029.8726.8220.05Price / Sales0.3970.43393.28116.44Price / CashN/A51.0838.2534.62Price / Book3.876.346.874.61Net Income-$15.55M$67.64M$3.22B$248.19M7 Day Performance9.43%21.94%6.81%2.97%1 Month Performance20.00%26.54%13.71%16.58%1 Year Performance14.47%22.75%18.30%8.16% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray2.4384 of 5 stars$1.62-7.2%N/A+8.7%$166.37M$465.25M-32.301,040Analyst DowngradeGap UpOFIXOrthofix Medical3.4931 of 5 stars$12.43+2.6%$23.33+87.7%-20.6%$485.04M$804.53M-3.971,090Gap UpANGOAngioDynamics4.4821 of 5 stars$9.57+5.0%$14.00+46.3%+63.7%$388.61M$283.32M-1.70760News CoveragePositive NewsSRDXSurmodics4.2927 of 5 stars$27.09+1.2%$43.00+58.7%-15.3%$387.36M$121.58M-26.82450Positive NewsRMTIRockwell Medical4.1944 of 5 stars$1.04-7.1%$4.00+284.6%-40.6%$35.54M$101.49M-20.80300Analyst RevisionGap UpRSLSReShape Lifesciences0.2413 of 5 stars$6.01-9.8%N/A-98.1%$2.71M$8.01M-0.0250News CoverageEarnings ReportGap DownABTAbbott Laboratories4.8926 of 5 stars$131.90-1.0%$142.59+8.1%+30.9%$229.49B$42.34B17.24115,000News CoveragePositive NewsISRGIntuitive Surgical4.327 of 5 stars$561.43+4.6%$598.95+6.7%+39.3%$201.23B$8.71B87.5912,100Positive NewsBSXBoston Scientific4.2424 of 5 stars$102.76-0.1%$114.52+11.4%+41.3%$152.02B$17.55B82.2145,000Positive NewsOptions VolumeSYKStryker4.9296 of 5 stars$387.97+1.9%$427.05+10.1%+18.1%$148.08B$23.22B50.0051,000Trending NewsMDTMedtronic4.5332 of 5 stars$85.70+2.7%$96.14+12.2%+1.9%$109.91B$33.20B26.0595,000Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastOptions Volume Related Companies and Tools Related Companies OFIX Alternatives ANGO Alternatives SRDX Alternatives RMTI Alternatives RSLS Alternatives ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARAY) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.